Home › Products › Oncology › Palbomed 125mg Capsule
Palbomed 125mg Capsule
Salt Composition: PALBOCICLIB
- Manufacturer: MEDICAMEN BIOTECH LTD
- Pack Size: 21 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 125MG
- Prescription Required
₹4688.00₹13500.00
Inclusive of all taxes
Product Introduction
Palbomed 125 mg is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as cyclin-dependent kinase inhibitors. Palbomed is used in slowing down cancer cell growth and prolonging progression-free survival in patients with hormone receptor-positive, HER2-negative breast cancer. Palbomed capsule is a generic formulation of palbociclib used in the treatment of advanced hormone receptor-positive, HER2-negative breast cancer. While Palbomed is one palbociclib-based option, some patients and healthcare providers also compare it with Pabreca, another formulation of palbociclib. Discussions around Pabreca usage often focus on its role in similar hormone receptor-positive, HER2-negative metastatic breast cancer cases. When evaluating Pabreca versus palbociclib brand efficacy, current evidence suggests comparable therapeutic outcomes, although individual responses may vary. Additionally, the Palbomed 125 mg price may differ depending on the pharmacy and region, and cost considerations often influence treatment decisions. The typical Palbomed dosage is 125 mg taken once daily for 21 days, followed by a 7-day break, completing a 28-day treatment cycle. Dosage adjustments may be made based on tolerance and blood test results.
Uses
Palbociclib 125 mg uses are: Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Palbomed 125 mg Capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take Palbomed 125 mg Capsule exactly as prescribed by your doctor. Take this medication once a day at the same time as food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
palbociclib side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. palbomed 125mg capsule side effects include Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts Decreased of appetite Nausea, vomiting Diarrhea Swelling of lips and mouth Changes in taste Nose bleed Dry eye, blurred vision, increased tearing
Expert Tips
During Palbomed 125 mg Capsule treatment, it is advised to avoid grapefruit and its juices and preparations containing St. John's wort. It Avoid grapefruit and St. John's wort: Do not consume grapefruit, its juice, or any products containing St. John's wort during Palbomed 125 mg Capsule treatment. Use effective contraception: Females: Use birth control during treatment and for at least 3 weeks after the final dose. Males: Continue birth control for at least 14 weeks after the final dose. Fertility concerns: This medicine may reduce fertility in both men and women. Speak to your doctor if you are planning to have children in the future. Regular blood tests: Your doctor may recommend routine blood tests to monitor how the medication is affecting your blood cell counts.
References
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: unsafe It is not recommended to take Palbomed 125 mg Capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult your doctor It is not unknown whether palbomed 125 mg can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: unsafe It is not recommended to take Palbomed 125 mg Capsule while breastfeeding as it is not known whether it passes into the breast milk.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.